每经AI快讯,据百奥智汇消息,Analytical BioSciences Limited(简称“百奥智汇”)及其子公司上海星赛生物科技有限公司近日宣布与吉利德科学(Gilead Sciences Inc.)签署资产购买协议。本次协议涉及百奥智汇在癌症免疫疗法中开创的新方法,通过重编程肿瘤微环境中的癌相关成纤维细胞(CAFs)诱导三级淋巴结构(TLS)的形成。 (文章来源:每日经济新闻)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.